Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00112_DB01268_nanopub.RA-zh0iCMqiPtC_wNdL1FUp94FpzRO0yx0OitJuG1TEk4#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00112_DB01268 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00112_DB01268 label "DDI between Bevacizumab and Sunitinib - Sunitinib may enhance the adverse/toxic effect of bevacizumab. Specifically, the risk for a specific form of anemia, microangiopathic hemolytic anemia (MAHA), may be increased. Bevacizumab may enhance the hypertensive effect of sunitinib. This combination is contraindicated. [drugbank_resource:DB00112_DB01268]" assertion.
- drugbank_resource:DB00112_DB01268 identifier "drugbank_resource:DB00112_DB01268" assertion.
- drugbank_resource:DB00112_DB01268 title "DDI between Bevacizumab and Sunitinib - Sunitinib may enhance the adverse/toxic effect of bevacizumab. Specifically, the risk for a specific form of anemia, microangiopathic hemolytic anemia (MAHA), may be increased. Bevacizumab may enhance the hypertensive effect of sunitinib. This combination is contraindicated." assertion.
- drugbank:DB01268 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00112_DB01268 assertion.
- drugbank:DB00112 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00112_DB01268 assertion.